GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (NEOE:JNJ) » Definitions » Shiller PE Ratio

Johnson & Johnson (NEOE:JNJ) Shiller PE Ratio : 20.74 (As of May. 08, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Johnson & Johnson Shiller PE Ratio?

As of today (2024-05-08), Johnson & Johnson's current share price is C$19.91. Johnson & Johnson's E10 for the quarter that ended in Mar. 2024 was C$0.96. Johnson & Johnson's Shiller PE Ratio for today is 20.74.

The historical rank and industry rank for Johnson & Johnson's Shiller PE Ratio or its related term are showing as below:

NEOE:JNJ' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.28   Med: 25.92   Max: 33.32
Current: 20.79

During the past years, Johnson & Johnson's highest Shiller PE Ratio was 33.32. The lowest was 19.28. And the median was 25.92.

NEOE:JNJ's Shiller PE Ratio is ranked better than
60.45% of 531 companies
in the Drug Manufacturers industry
Industry Median: 25.44 vs NEOE:JNJ: 20.79

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2024 was C$1.814. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is C$0.96 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Johnson & Johnson Shiller PE Ratio Historical Data

The historical data trend for Johnson & Johnson's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Shiller PE Ratio Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.45 31.45 29.88 28.15 21.67

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.91 26.23 21.48 21.67 22.12

Competitive Comparison of Johnson & Johnson's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.



Johnson & Johnson Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=19.91/0.96
=20.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.814/129.4194*129.4194
=1.814

Current CPI (Mar. 2024) = 129.4194.

Johnson & Johnson Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 1.635 100.560 2.104
201409 1.828 100.428 2.356
201412 1.026 99.070 1.340
201503 1.931 99.621 2.509
201506 1.991 100.684 2.559
201509 1.592 100.392 2.052
201512 1.577 99.792 2.045
201603 2.103 100.470 2.709
201606 1.844 101.688 2.347
201609 2.006 101.861 2.549
201612 1.841 101.863 2.339
201703 2.155 102.862 2.711
201706 1.861 103.349 2.330
201709 1.682 104.136 2.090
201712 -5.095 104.011 -6.340
201803 2.069 105.290 2.543
201806 1.903 106.317 2.317
201809 1.877 106.507 2.281
201812 1.505 105.998 1.838
201903 1.859 107.251 2.243
201906 2.764 108.070 3.310
201909 0.874 108.329 1.044
201912 1.975 108.420 2.358
202003 3.029 108.902 3.600
202006 1.843 108.767 2.193
202009 1.760 109.815 2.074
202012 0.833 109.897 0.981
202103 2.916 111.754 3.377
202106 2.872 114.631 3.243
202109 1.736 115.734 1.941
202112 2.266 117.630 2.493
202203 2.443 121.301 2.607
202206 2.305 125.017 2.386
202209 2.241 125.227 2.316
202212 1.807 125.222 1.868
202303 -0.041 127.348 -0.042
202306 2.604 128.729 2.618
202309 13.815 129.860 13.768
202312 2.240 129.419 2.240
202403 1.814 129.419 1.814

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Johnson & Johnson  (NEOE:JNJ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Johnson & Johnson Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (NEOE:JNJ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.